Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.15 is 75% below its 5-year average of 0.61, near the low end of its 5-year range (0.02–2.35).
As of the fiscal period ended Wednesday, December 31, 2025. 81.73% below its 12-month average of 0.81.
Reported quarterly current ratio; no daily interpolation. Q2 FY2025 (2025-12-31): 0.15.
CURRENT RATIO
0.15
CURRENT RATIO AVG TTM
0.81
CURRENT RATIO AVG 3Y
0.86
CURRENT RATIO AVG 5Y
0.61
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-81.73%
CURRENT VS 3Y AVG
-82.64%
CURRENT VS 5Y AVG
-75.47%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-96.04%
vs the sector median at left
Market Cap
$3.25M
Current Ratio
8.18
TTM Avg
4.65
3Y Avg
2.72
5Y Avg
3.39
Market Cap
$3.67M
Current Ratio
3.73
TTM Avg
3.25
3Y Avg
4.33
5Y Avg
4.33
Market Cap
$3.70M
Current Ratio
1.37
TTM Avg
1.71
3Y Avg
1.30
5Y Avg
1.21
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.46M | 0.15 | 0.81 | 0.86 | 0.61 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 1.97 | 1.45 | 2.21 | 4.94 |
| Nexalin Technology, Inc. (NXL)vs › | $3.53M | 1.25 | 6.05 | 6.00 | 4.06 |
| Eocene Ltd. (EOCN)vs › | $3.57M | N/A | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | 8.18 | 4.65 | 2.72 | 3.39 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.67M | 3.73 | 3.25 | 4.33 | 4.33 |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.70M | 1.37 | 1.71 | 1.30 | 1.21 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.75M | 2.01 | 0.91 | 1.26 | 1.78 |
| Evogene Ltd. (EVGN)vs › | $3.74M | 3.57 | 2.84 | 4.34 | 5.17 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.24M | 5.42 | 3.49 | 5.10 | 6.32 |
Current Ratio
0.15
Quick Ratio
0.08
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 0.15 |
| 2024-12-31 | 1.48 |
| 2024-09-30 | 1.51 |
| 2024-06-30 | 1.69 |
| 2024-03-31 | 0.85 |
| 2023-12-31 | 0.43 |
| 2023-09-30 | 0.26 |
| 2023-06-30 | 0.42 |
| 2023-03-31 | 0.85 |
| 2022-12-31 | 0.93 |
| 2022-09-30 | 0.04 |
| 2022-06-30 | 0.27 |
| 2022-03-31 | 0.23 |
| 2021-12-31 | 0.14 |
| 2021-09-30 | 0.37 |
| 2021-06-30 | 0.67 |
| 2021-03-31 | 2.35 |
| 2020-12-31 | 0.02 |
